New drug shows promise for becker muscular dystrophy in early trial
NCT ID NCT05166109
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 30 times
Summary
This study tested a drug called vamorolone in 46 males with Becker muscular dystrophy, a muscle-weakening disease. Participants took either vamorolone or a placebo daily for 24 weeks. The main goal was to check safety and side effects, while also looking at how the drug moves through the body and if it helps muscle function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BECKER MUSCULAR DYSTROPHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Azienda Ospedale Universita Padova
Padova, 35129, Italy
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15261, United States
Conditions
Explore the condition pages connected to this study.